Volume 5

Accreditation Statements

Physicians
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Johns Hopkins University School of Medicine and the Institute for Johns Hopkins Nursing. The Johns Hopkins University School of Medicine is accredited by the ACCME to provide continuing medical education for physicians.

Nurses
The Institute for Johns Hopkins Nursing is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.

Credit Designations

Physicians
eNewsletter: The Johns Hopkins University School of Medicine designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Podcast: The Johns Hopkins University School of Medicine designates this enduring material for a maximum of 0.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity

Nurses

eNewsletter: This 1 contact hour Educational Activity is provided by the Institute for Johns Hopkins Nursing. Each Newsletter carries a maximum of 1 contact hour, or a total of 6 contact hours for the 6 newsletters in this program.
Podcast: These paired 0.5 contact hour Educational Activities are provided by the Institute for Johns Hopkins Nursing. Each podcast carries a maximum of 0.5 contact hour, or a total of 3 contact hours for the 6 podcasts in this program.

Course Format

The eViralHepatitis Review series will consist of a monthly review of journal literature on key, pertinent topics, emailed as either a newsletter or podcast, to clinicians caring for patients with hepatitis. The timely commentary on current research, best practices and clinical management issues is provided by an expert panel of hepatitis specialists. The activities are delivered as 6 bi-monthly newsletters and 6 alternating podcasts. Participants will have up to 2 years to complete the 6 newsletters and 6 podcasts in order to earn CME credit.

Date of release: February 23, 2017
Expiration date: January 24, 2020

Estimated time to complete each activity: 60 minutes per newsletter, 30 minutes per podcast

Learning Objectives

After participating in this activity, the participant will demonstrate the ability to:

• Identify screening recommendations by the CDC and demonstrate its practical application.
• Evaluate current HCV treatment options and determine which therapies will be most effective for each patient.
• Explain the challenges of managing HCV in special populations such as advanced age, co-infection with HIV, and chronic kidney disease.
• Describe the important advances in HCV management with new treatments currently in development.
• Discuss how to better manage complicated HCV infection including treatment failure and reinfection.
• Apply approved USPSTF guidelines for HBV screening and prevention to clinical practice.
• Utilize current treatment guidelines and recent clinical data to manage HBV infection in your patients.
• Describe the mechanisms of action, efficacy, and safety issues of available and emerging therapeutic agents for HBV.

Statement of Responsibility

The Johns Hopkins University School of Medicine takes responsibility for the content, quality, and scientific integrity of this CME activity.

Statement of Need

• Clinicians do not appropriately screen for HCV, leaving many patients with HCV infection unidentified.
• Clinicians’ knowledge of current HCV treatment options is inadequate to provide the most effective individualized care.
• Clinical decision-making will benefit from increased knowledge of real-world use of all-oral treatment regimens for HCV in special populations.
• Clinicians’ knowledge of new phase II/III HCV therapies is limited.
• Clinicians’ confidence in managing complicated HCV infections is inadequate to provide appropriate care.
• Many clinicians are unfamiliar with guidelines for HBV screening and prevention.
• Many clinicians are unaware of current treatment guidelines and recent clinical data for evolving approaches to HBV treatment.
• Clinicians have a poor understanding of the complex HBV viral lifecycle and the therapeutic targets of current and emerging agents.

Supported by educational grants from Gilead Sciences, Inc., AbbVie, Inc., and Merck & Co., Inc.

Successful Completion

To receive credit, participants must (1) read the learning objectives and disclosure statements, (2) complete the educational activity, and (3) complete the post-test and activity evaluation form, including the certificate information section. Physicians must attest to the amount of time they spent on the activity.

A passing grade of 70% or higher on the post-test/evaluation is required to receive CE credit.

Intended Audience

The target audience (clinicians) for this initiative includes primary care physicians (PCPs), OB/GYNs, NPs, PAs, hepatologists, gastroenterologists, infectious disease physicians, and others involved in the care of patients with hepatitis.

There are no prerequisites.

Internet CME Policy

The Office of Continuing Medical Education (CME) at the Johns Hopkins University School of Medicine is committed to protecting the privacy of its members and customers. The Johns Hopkins University SOM CME maintains its Internet site as an information resource and service for physicians, other health professionals, and the public.

Continuing Medical Education at the Johns Hopkins University School of Medicine will keep your personal and credit information confidential when you participate in an Internet-based CME program. Your information will never be given to anyone outside of the Johns Hopkins University School of Medicine's CME program. CME collects only the information necessary to provide you with the services that you request.

To participate in additional CME activities presented by the Johns Hopkins University School of Medicine Continuing Medication Office, please visit www.hopkinscme.cloud-cme.com.

Planners Disclosures

As a provider approved by the Accreditation Council for Continuing Medical Education (ACCME), Johns Hopkins University School of Medicine Office of Continuing Medical Education (OCME) requires attested and signed global disclosure of the existence of all financial interests or relationships with commercial interest from any individual in a position to control the content of a CME activity sponsored by OCME. The following relationships have been reported for this activity:

Mark S. Sulkowski, MD discloses that he has served as a principal investigator for AbbVie, Inc., Janssen, Gilead Sciences, Inc., Merck & Co., Inc., and Tobira. He has received consulting fees from AbbVie, Inc., Cocrystal, Trek, Gilead Sciences, Inc., Janssen, and Merck & Co., Inc.

Raymond T. Chung, MD discloses that he has served as a principal investigator for Gilead Sciences, Inc., AbbVie, Inc., Merck & Co., Inc., and Bristol-Myers Squibb.

No other planners have indicated that they have any financial interest or relationships with a commercial entity.

Note: Grants to investigators at The Johns Hopkins University are negotiated and administered by the institution which receives the grants, typically through the Office of Research Administration. Individual investigators who participate in the sponsored project(s) are not directly compensated by the sponsor, but may receive salary or other support from the institution to support their effort on the project(s).

Privacy Policy

The Office of Continuing Medical Education (CME) at the Johns Hopkins University School of Medicine is committed to protecting the privacy of its members and customers. Johns Hopkins University SOM CME maintains its Internet site as an information resource and service for physicians, other health professionals and the public. Continuing Medical Education at the Johns Hopkins University School of Medicine will keep your personal and credit information confidential when you participate in a CME Internet based program. Your information will never be given to anyone outside of the Johns Hopkins University School of Medicine's CME program. CME collects only the information necessary to provide you with the services that you request.

To participate in additional CME activities presented by the Johns Hopkins University School of Medicine Continuing Medical Education Office, please visit www.hopkinscme.cloud-cme.com

Disclaimer Statement

The opinions and recommendations expressed by faculty and other experts whose input is included in this program are their own. This enduring material is produced for educational purposes only. Use of the Johns Hopkins University School of Medicine name implies review of educational format design and approach. Please review the complete prescribing information of specific drugs or combination of drugs, including indications, contraindications, warnings, and adverse effects before administering pharmacologic therapy to patients.

Confidentiality Disclaimer for CME Activity Participants

I certify that I am participating in a Johns Hopkins University School of Medicine CME activity for accredited training and/or educational purposes.

I understand that while I am participating in this capacity, I may be exposed to "protected health information," as that term is defined and used in Hopkins policies and in the federal HIPAA privacy regulations (the Privacy Regulations). Protected health information is information about a person's health or treatment that identifies the person.

I pledge and agree to use and disclose any of this protected health information only for the training and/or educational purposes of my visit and to keep the information confidential. I agree not to post or discuss this protected health information, including pictures and/or videos on any social medial site (e.g. Facebook, Twitter, etc.), in any electronic messaging program or through any portable electronic device.

I understand that I may direct to the Johns Hopkins Privacy Officer any questions I have about my obligations under this Confidentiality Pledge or under any of the Hopkins policies and procedures and applicable laws and regulations related to confidentiality. The contact information is Johns Hopkins Privacy Officer, telephone: 410-735-6509, e-mail: HIPAA@jhmi.edu.

"The Office of Continuing Medical Education at The Johns Hopkins University School of Medicine, as provider of this activity, has relayed information with the CME attendees/participants and certifies that the visitor is attending for training, education and/or observation purposes only."

For CME questions, please contact the CME Office (410) 955-2959 or e-mail cmenet@jhmi.edu. For certificates, please call (410) 502-9634.

Johns Hopkins University School of Medicine Office of Continuing Medical Education
Turner 20/720
Rutland Avenue
Baltimore, Maryland 21205-2195

Reviewed & Approved by:
General Counsel, Johns Hopkins Medicine (4/1/03)
(Updated 4/09 and 3/14)

Hardware & Software Requirements

To access activities, users will need:

• A computer with an internet connection
• An HTML5 compliant web browser or Internet Explorer 8 (and higher)

Copyright © JHUSOM and eViralHepatitis Review | Presented by JHUSOM in collaboration with DKBmed.